IM Cannabis to Sell European Assets, Cut Debt by C$10.5M Amid Financial Hardship
Summary
IM Cannabis Corp. has entered a non-binding letter of intent to sell its European operations to an entity controlled by its CEO, expecting to reduce its debt by C$10.5 million. This move is critical for the company, which recently issued a going concern warning and received a Nasdaq bid price non-compliance notice, following a series of highly dilutive convertible note financings. The transaction, which is a related-party deal, relies on "financial hardship" exemptions for minority shareholder approval, underscoring the urgency of the company's financial situation. The sale aims to streamline operations and allow the company to focus on its core Israeli business. The transaction is subject to a definitive agreement and special committee approval.
At the time of this announcement, IMCC was trading at $0.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4M. The 52-week trading range was $0.21 to $3.75. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: PR Newswire.